Merck's Munificence: Ex-Schering CEO Fred Hassan Walks Away With $50M | BNET Pharma Blog | BNET

via industry.bnet.com

TRENTON, N.J.- Merck & Co.'s chief executive, who oversaw the drug maker's acquisition of Schering-Plough Corp. last fall, received a compensation package valued at $11.9 million in 2009, according to an Associated Press calculation of figures disclosed in a regulatory filing Merck made late Monday. Richard T. Clark's total compensation fell 31...

Posted via web from ElyssaD's Posterous